Stretching Semaglutide to Every 9 or 10 Days: What the PK Allows

A small but determined community is taking semaglutide every 9 days — or every 10, or every 11. The motivations vary: stretching a vial to save money, riding out a side-effect plateau, easing into a "maintenance" routine after hitting a goal weight, or simply hating the idea of reconstituting more often than necessary.

If you understand the half-life, the strategy isn't crazy. It's also not as forgiving as people sometimes claim. Here's where the pharmacokinetics back you up — and the two scenarios where stretching the interval quietly stops working.

The math: why a 7-day interval isn't pharmacologically sacred

Semaglutide's elimination half-life is about 165 hours, or roughly 6.9 days. That's the entire reason 7 days became the standard interval — it's just slightly longer than one half-life, which produces a steady-state plasma curve with a peak-to-trough ratio of about 1.3 to 1 once you're loaded in.

Push the interval out to 9 days and the math shifts modestly. Each new dose lands a little closer to where the previous one has decayed. The trough is lower. The peak is still high, but the area under the curve over a longer window is reduced, because you're injecting less drug per unit time.

Practically, every 9 days is roughly equivalent to taking 78% of your weekly dose every week, smeared over a slightly bouncier curve. Every 10 days drops that effective weekly dose to about 70%. Every 14 days — every other week — is around 50%.

These are approximations using one-compartment elimination kinetics — your body isn't exactly that simple, but for everyday decisions the numbers are close enough.

When stretching is a reasonable strategy

The interval-extension move actually does a few things that the simple "lower your weekly dose" alternative doesn't:

• You preserve the weekly peak. A larger dose less often produces a higher peak than a smaller dose more often. For some users, that intermittent peak is what keeps appetite suppression strong while reducing total exposure.
• You stretch supply. Compounded users typically pay per vial. Going from every 7 to every 10 days is a 30% cost reduction without a clinician change.
• You reduce total side-effect burden. Less drug per unit time, even with the same peak, often means less cumulative GI fatigue and less pull on the gallbladder.

The clearest fit for stretching: someone in maintenance mode — they've hit their goal weight, want to stay on a low effective dose for appetite anchoring, and value supply economy. For them, every 9 or 10 days at their current vial strength is often a clean substitute for dropping to a lower dose at a tighter interval.

Where stretching breaks down

Two scenarios where the math stops being your friend:

1. The first-month / titration window

If you're not yet at steady state — roughly the first 4–5 weeks of any new dose — stretching the interval starves the loading process. Each week's injection is supposed to add to a building plasma reservoir; if you're injecting every 10 days during titration, you're injecting 3 times in the period that the protocol assumes 4 or 5.

The result is that you reach a lower steady-state level than the dose is supposed to produce. People sometimes do this without realizing it — they're titrating, they feel underwhelmed, and they extend the interval thinking it'll smooth side effects. They get fewer side effects, but they also stop building the dose. Weight loss stalls, and they (incorrectly) blame "non-response."

If you want a smoother first month, micro-titration (slower step-ups, smaller increments) is the lever to pull, not interval extension. Our semaglutide dosing schedule cluster has more on what slow titration looks like.

2. Micro-dose users

If you're already on a low maintenance dose — say 0.25 mg or 0.5 mg weekly — stretching to every 9 or 10 days drops your effective weekly dose to a level that often loses appetite suppression entirely.

This is because the dose-response curve for GLP-1 agonism is not linear at the low end. The first 0.25 mg of semaglutide produces a disproportionately small effect; the next 0.5 mg produces a much larger one; and so on. Stretching from 0.5 mg/week to 0.5 mg/10 days isn't 70% of the effect — for many people it's closer to 50%, because you're sliding back down a steep portion of the curve.

If you're at a low maintenance dose and want to stretch, the better move is often to go to a higher dose and stretch the interval, keeping your effective weekly mg roughly constant but at a more reliable point on the dose-response curve. That's a clinician-level decision — not something to freelance from a forum thread.

What the data says (and doesn't say)

There are no published Phase 3 trials of semaglutide at intervals other than once-weekly for the injectable forms. Every major trial — STEP, SUSTAIN, SELECT — used weekly dosing. The pharmacokinetic argument for extended intervals is mechanistic (steady-state math, half-life dynamics) rather than outcome-based.

That doesn't make it wrong. Semaglutide's PK is well-characterized, and the math is sound. But it does mean:

• You're running a single-person experiment. Track your weight, side effects, and appetite trajectory honestly. If something drifts, the interval is the variable to revisit first.
• Don't combine multiple variables. If you stretch the interval and drop the dose and change brands, you can't tell which one changed your results.
• Your clinician should know. Even if they don't formally endorse it, they need the real picture for HbA1c interpretation and dose decisions.

A practical playbook for stretching

If, after considering the above, every-9-or-10-day dosing still makes sense for you:

1. Wait until you've hit steady state on your current dose — at least 4–5 weeks at the same weekly mg before extending the interval
2. Move in one-day increments — go from 7 to 8 days for a couple of cycles before going to 9, watch how your appetite and weight respond
3. Don't extend during a step-up. If you've just bumped to a new dose, finish loading first
4. Track injection date, not "Sunday-ish." A floating "every 9 days roughly" tends to drift to every 11–12, which crosses into territory the math is less kind to
5. Reassess at 12 weeks. Compare weight trend and appetite control to your previous 12 weeks at weekly dosing — if either drifts noticeably, the interval is the first thing to tighten

For users on a stable dose who've reached their goal, the interval-extension question often gets entangled with the bigger question of whether to stay on the drug at all — see stopping semaglutide for what regain looks like off-drug.

Where to go from here

• Splitting a weekly dose — the pharmacokinetic mirror image of this question
• Semaglutide: complete guide — the pillar overview
• Semaglutide dosing schedule — standard titration ladder
• Reconstitution calculator — for compounded users

The half-life is forgiving but not infinite. Stretch with intention, watch the data, and remember that "every 9 days" is just another point on a curve — not a different drug.